Login

Pharmaceutical Manufacturer Fills Big Block of Space in Former Cisco Facility

Vibalogics Selects Boxborough, Massachusetts, Site to Establish a Virotherapy Manufacturing Operation in the US
Private equity-backed Vibalogics is making a $150 million investment to establish a virotherapy facility in a Lincoln Property-owned facility near Boston. (CoStar)
Private equity-backed Vibalogics is making a $150 million investment to establish a virotherapy facility in a Lincoln Property-owned facility near Boston. (CoStar)
By Samantha Wassum
CoStar Research
November 24, 2020 | 1:44 AM

Vibalogics, a pharmaceutical contract development and manufacturing organization based in Germany, has selected a former Cisco Systems facility near Boston where it plans to make a $150 million investment to equip and staff a late-phase clinical and commercial virotherapy manufacturing facility as part of its plans to build a presence in the U.S.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE